Chemical inhibitors of apolipoprotein L 7c can exert functional inhibition through various biochemical mechanisms. Marimastat, for example, inhibits metalloproteinases that are involved in the processing or degradation of apolipoprotein L 7c, which could be essential for its proper functioning within the lipid metabolism pathways. Similarly, E-64 targets cysteine proteases that are responsible for the cleavage and subsequent activation of apolipoprotein L 7c, thereby inhibiting its functional activity. Leupeptin, through its action on serine and cysteine proteases, leads to an inhibition of apolipoprotein L 7c by obstructing the activation process that is crucial for its function. Pepstatin A inhibits aspartyl proteases, which may be involved in the maturation process of apolipoprotein L 7c, thus impeding its capacity to bind lipids effectively.
Further down the cellular pathway, Bafilomycin A1 disrupts vacuolar H+-ATPases, which could inhibit the acidification required for the intracellular trafficking of apolipoprotein L 7c, leading to the functional inhibition of the protein. MG-132 inhibits the proteasome, which is crucial for the degradation of misfolded proteins, including apolipoprotein L 7c, resulting in the accumulation of non-functional forms of the protein. Phenylarsine Oxide acts by inhibiting tyrosine phosphatases, altering signaling pathways that are necessary for the activity of apolipoprotein L 7c, leading to its inhibition. Inhibition of PI3K by LY294002 and Wortmannin disrupts essential signaling pathways, culminating in the inhibition of apolipoprotein L 7c activity. Z-VAD-FMK, a caspase inhibitor, can prevent the apoptotic degradation of cells expressing apolipoprotein L 7c, potentially preserving non-functional forms of the protein and thus inhibiting its function. ALLN targets calpains and inhibits the turnover of apolipoprotein L 7c, which may lead to the accumulation of inhibitory fragments of the protein. Finally, Gö6976 inhibits protein kinase C, potentially preventing phosphorylation-dependent processes that are necessary for the proper function of apolipoprotein L 7c.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $165.00 $214.00 $396.00 $617.00 $4804.00 | 19 | |
Inhibits metalloproteinases that may be involved in the processing or degradation of apolipoprotein L 7c, thereby inhibiting its functional activity. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $275.00 $928.00 $1543.00 | 14 | |
Inhibits cysteine proteases that could be responsible for the cleavage and activation of apolipoprotein L 7c, resulting in inhibition of the protein's function. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $72.00 $145.00 $265.00 $489.00 $1399.00 $99.00 | 19 | |
Targets serine and cysteine proteases which may be crucial for the activation of apolipoprotein L 7c, leading to an inhibition of its function. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Disrupts vacuolar H+-ATPases, potentially inhibiting the acidification required for the intracellular trafficking of apolipoprotein L 7c, leading to functional inhibition. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Inhibits the proteasome, preventing the degradation of misfolded apolipoprotein L 7c proteins, which could inhibit their function by causing an accumulation of the non-functional form. | ||||||
Phenylarsine oxide | 637-03-6 | sc-3521 | 250 mg | $40.00 | 4 | |
Inhibits tyrosine phosphatases, potentially altering signaling pathways that could be necessary for the activity of apolipoprotein L 7c, thus leading to its functional inhibition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K which is involved in signaling pathways essential for apolipoprotein L 7c function, leading to inhibition of its activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits PI3K, which can disrupt signaling pathways necessary for the function of apolipoprotein L 7c, leading to functional inhibition. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $74.00 | 256 | |
Inhibits caspases that could be involved in the apoptotic degradation of cells expressing apolipoprotein L 7c, potentially inhibiting its function by preserving non-functional forms. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $223.00 | 8 | |
Inhibits protein kinase C which is implicated in phosphorylation of proteins, and could inhibit phosphorylation-dependent processes necessary for the function of apolipoprotein L 7c. |